EGFR and head and neck squamous cell carcinoma: As proposed in the model in Fig. 6C, in the presence of viral genes, EGFR could adopt an alternative pathway through miR-9-5p resulting in the suppression BRD4 as well as HPV E6/E7 oncoproteins in HPV-positive HNSCC consequently improving treatment response.